Literature DB >> 32039289

Programmed colorectal cancer screening decreases incidence and mortality.

Susana Roselló1, Soraya Simón1, Andrés Cervantes1.   

Abstract

Entities:  

Year:  2019        PMID： 32039289      PMCID： PMC6987332          DOI： 10.21037/tgh.2019.12.13

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  23 in total

Review 1.  Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.

Authors:  Jill Tinmouth; Iris Lansdorp-Vogelaar; James E Allison
Journal:  Gut       Date:  2015-06-03       Impact factor: 23.059

2.  Colorectal Cancer on the Decline--Why Screening Can't Explain It All.

Authors:  H Gilbert Welch; Douglas J Robertson
Journal:  N Engl J Med       Date:  2016-04-28       Impact factor: 91.245

3.  Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.

Authors:  Partha Basu; Antonio Ponti; Ahti Anttila; Guglielmo Ronco; Carlo Senore; Diama Bhadra Vale; Nereo Segnan; Mariano Tomatis; Isabelle Soerjomataram; Maja Primic Žakelj; Joakim Dillner; Klara Miriam Elfström; Stefan Lönnberg; Rengaswamy Sankaranarayanan
Journal:  Int J Cancer       Date:  2017-10-10       Impact factor: 7.396

4.  Association of polypectomy techniques, endoscopist volume, and facility type with colonoscopy complications.

Authors:  Askar Chukmaitov; Cathy J Bradley; Bassam Dahman; Umaporn Siangphoe; Joan L Warren; Carrie N Klabunde
Journal:  Gastrointest Endosc       Date:  2013-01-04       Impact factor: 9.427

5.  Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.

Authors:  Amy B Knudsen; Ann G Zauber; Carolyn M Rutter; Steffie K Naber; V Paul Doria-Rose; Chester Pabiniak; Colden Johanson; Sara E Fischer; Iris Lansdorp-Vogelaar; Karen M Kuntz
Journal:  JAMA       Date:  2016-06-21       Impact factor: 56.272

6.  Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: a SEER-based analysis with comparison to other young-onset cancers.

Authors:  Abhishek Bhandari; Melissa Woodhouse; Samir Gupta
Journal:  J Investig Med       Date:  2016-11-18       Impact factor: 2.895

7.  Do no harm: no psychological harm from colorectal cancer screening.

Authors:  Benedicte Kirkøen; Paula Berstad; Edoardo Botteri; Tone Lise Åvitsland; Alvilde Maria Ossum; Thomas de Lange; Geir Hoff; Tomm Bernklev
Journal:  Br J Cancer       Date:  2016-02-11       Impact factor: 7.640

8.  The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.

Authors:  Elisabeth F P Peterse; Reinier G S Meester; Rebecca L Siegel; Jennifer C Chen; Andrea Dwyer; Dennis J Ahnen; Robert A Smith; Ann G Zauber; Iris Lansdorp-Vogelaar
Journal:  Cancer       Date:  2018-05-30       Impact factor: 6.860

9.  Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels.

Authors:  L Hol; J A Wilschut; M van Ballegooijen; A J van Vuuren; H van der Valk; J C I Y Reijerink; A C M van der Togt; E J Kuipers; J D F Habbema; M E van Leerdam
Journal:  Br J Cancer       Date:  2009-04-07       Impact factor: 7.640

10.  Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population.

Authors:  Theodore R Levin; Douglas A Corley; Christopher D Jensen; Joanne E Schottinger; Virginia P Quinn; Ann G Zauber; Jeffrey K Lee; Wei K Zhao; Natalia Udaltsova; Nirupa R Ghai; Alexander T Lee; Charles P Quesenberry; Bruce H Fireman; Chyke A Doubeni
Journal:  Gastroenterology       Date:  2018-07-19       Impact factor: 22.682
View more
  5 in total

1.  CircTBL1XR1/miR-424 axis regulates Smad7 to promote the proliferation and metastasis of colorectal cancer.

Authors:  Na Li
Journal:  J Gastrointest Oncol       Date:  2020-10

Review 2.  Use of Omics Technologies for the Detection of Colorectal Cancer Biomarkers.

Authors:  Marina Alorda-Clara; Margalida Torrens-Mas; Pere Miquel Morla-Barcelo; Toni Martinez-Bernabe; Jorge Sastre-Serra; Pilar Roca; Daniel Gabriel Pons; Jordi Oliver; Jose Reyes
Journal:  Cancers (Basel)       Date:  2022-02-06       Impact factor: 6.639

3.  Impact of changes to the interscreening interval and faecal immunochemical test threshold in the national bowel cancer screening programme in England: results from the FIT pilot study.

Authors:  Shuping J Li; Tara Seedher; Linda D Sharples; Sally C Benton; Christopher Mathews; Rhian Gabe; Peter Sasieni; Stephen W Duffy
Journal:  Br J Cancer       Date:  2022-08-17       Impact factor: 9.075

4.  Overexpression of UBE2M through Wnt/β-Catenin signaling is associated with poor prognosis and chemotherapy resistance in colorectal cancer.

Authors:  Jianmin Xu; Guoqiang Lv; Binghua Xu; Bin Jiang
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

5.  Upregulation of STAT1-CCL5 axis is a biomarker of colon cancer and promotes the proliferation of colon cancer cells.

Authors:  Mengke Niu; Ming Yi; Bing Dong; Suxia Luo; Kongming Wu
Journal:  Ann Transl Med       Date:  2020-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.